Cathcart-RakeW, BoneRC, SobonyaRE, StephensRL. Rapid development of diffuse pulmonary infiltrates in histocytic lymphoma. Am Rev Respir Dis1978;117:587–593.
2.
BradyM, HunninghakeGA, ShasbyDM, MoseleyPL. Lung parenchymal injury induced by bleomycin. Am Rev Respir Dis1984;130:1082–1086.
3.
Van BarenveldPWC, Van Der MarkThW, SleijferDT, . Predictive factors for bleomycin-induced pneumonitis. Am Rev Respir Dis1984;130:1078–1081.
4.
HoloyePY, LunaMA. Bleomycin hypersensitivity pneumonitis. Ann Intern Med1978;88:47–49.
CooperJADJr, WhiteDA, MatthayRA. Drug-induced pulmonary disease (state of art). Part I: Cytoxic drugs. Am Rev Respir Dis1986;133:321–340.
7.
BrownWG, HasanFM. Reversibility of severe bleomycin-induced pneumonitis. JAMA1978;239:2012–2014.
8.
SheinPS, DeVitaVT. Bleomycin, adriamycin, cyclophosphamide, vinicristine and prednisone combination chemotherapy in the treatment of advanced diffuse histocytic lymphoma. Ann Intern Med1978;85:417–422.
